UA75714U - method for treating chronic hepatitis C associated with liver fibrosis - Google Patents

method for treating chronic hepatitis C associated with liver fibrosis

Info

Publication number
UA75714U
UA75714U UAU201206674U UAU201206674U UA75714U UA 75714 U UA75714 U UA 75714U UA U201206674 U UAU201206674 U UA U201206674U UA U201206674 U UAU201206674 U UA U201206674U UA 75714 U UA75714 U UA 75714U
Authority
UA
Ukraine
Prior art keywords
liver fibrosis
chronic hepatitis
treating chronic
capsules
duoliton
Prior art date
Application number
UAU201206674U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Олена Анатоліївна Тараненко
Елена Анатолиевна Тараненко
Анатолій Васильович Доровських
Анатолий Васильевич Доровских
Світлана Вікторівна Орлик
Светлана Викторовна Орлик
Максим Юрійович Зак
Максим Юрьевич Зак
Original Assignee
Товариство З Обмеженою Відповідальністю Науково-Виробниче Об'Єднання "Міжнародний Медичний Центр"
Общество С Ограниченной Ответственностью Научно-Производственное Объединение «Международный Медицинский Центр»
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Товариство З Обмеженою Відповідальністю Науково-Виробниче Об'Єднання "Міжнародний Медичний Центр", Общество С Ограниченной Ответственностью Научно-Производственное Объединение «Международный Медицинский Центр» filed Critical Товариство З Обмеженою Відповідальністю Науково-Виробниче Об'Єднання "Міжнародний Медичний Центр"
Priority to UAU201206674U priority Critical patent/UA75714U/en
Publication of UA75714U publication Critical patent/UA75714U/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A method for treating chronic hepatitis C associated with liver fibrosis comprises the use of hepatoprotectors in the complex scheme of treatment and frequency-resonance therapy in antiviral mode. Additionally drugs of antifibrotic action are used, namely duoamiton 2 capsules in the morning, duoliton 2 capsules in the evening.
UAU201206674U 2012-05-31 2012-05-31 method for treating chronic hepatitis C associated with liver fibrosis UA75714U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201206674U UA75714U (en) 2012-05-31 2012-05-31 method for treating chronic hepatitis C associated with liver fibrosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201206674U UA75714U (en) 2012-05-31 2012-05-31 method for treating chronic hepatitis C associated with liver fibrosis

Publications (1)

Publication Number Publication Date
UA75714U true UA75714U (en) 2012-12-10

Family

ID=74307658

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201206674U UA75714U (en) 2012-05-31 2012-05-31 method for treating chronic hepatitis C associated with liver fibrosis

Country Status (1)

Country Link
UA (1) UA75714U (en)

Similar Documents

Publication Publication Date Title
AU2018201942B2 (en) Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan
MY189466A (en) Methods of modulating drug plasma levels using erythrohydroxybupropion
EA201590870A1 (en) AMINO-SUBSTITUTED IMIDAZO [1,2-a] Pyridinecarboxamides and their use
SG195110A1 (en) Pirfenidone and anti-fibrotic therapy in selected patients
MX2020012924A (en) Treatment of cancer using coenzyme q10 combination therapies.
NZ631144A (en) Compositions and methods for transmucosal absorption
MX2015010791A (en) Methods of treating cancer and preventing drug resistance.
PH12015501088A1 (en) Dimeric compounds
GB201302343D0 (en) Pharmaceutical compositions comprising 15-OHEPA and methods for using the same
NZ707636A (en) Ingenol-derived compounds that can be used for treating cancer
PH12017500617A1 (en) Dosage regimen for pegylated interferon
MX366309B (en) Pharmaceutical composition for treating inflammation and pain.
MX2014014816A (en) Pharmaceutical composition for treating inflammation and pain.
UA75714U (en) method for treating chronic hepatitis C associated with liver fibrosis
MX2013012551A (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease.
UA73001U (en) method for treating patients with pulmonary tuberculosis combined with HIV/AIDS
UA74878U (en) Method for treating psoriasis vulgaris
UA84284U (en) Method for treating mononucleosis in adult patients
UA83813U (en) Method for treating neurosyphilis with mesenchymal alterations
UA81083U (en) Method for treating acute respiratory viral infections
UA64067U (en) Method for treating patients with stevens-johnson syndrome
UA86338U (en) Method for treating gestational diabetes
UA100992U (en) Method of treatment hypertonic-hyperkinetic forms of biliary dyskinesia and vegetative disorders in patients with chronic acalculous cholecystitis
UA69222U (en) Method for reflexotherapy in patients with effects of traumatic brain injuries
UA84298U (en) Method for treating severe form of measles in adults